-Infinity
0
Severity
7.8
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

BD Totalys MultiProcessor, versions 1.70 and earlier, contain hardcoded credentials. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII). Customers using BD Totalys MultiProcessor version 1.70 with Microsoft Windows 10 have additional operating system hardening configurations which increase the attack complexity required to exploit this vulnerability.

First published (updated )
Severity
4.9
CVSS:3.0/AV:P/AC:H/PR:N/UI:N/S:C/C:H/I:N/A:N

An issue was discovered in Becton, Dickinson and Company (BD) Alaris 8015 Point of Care (PC) unit, Version 9.5 and prior versions, and Version 9.7, and 8000 PC unit. An unauthorized user with physical access to an affected Alaris PC unit may be able to obtain unencrypted wireless network authentication credentials and other sensitive technical data by disassembling the PC unit and accessing the device's flash memory. The Alaris 8015 PC unit, Version 9.7, and the 8000 PC unit store wireless network authentication credentials and other sensitive technical data on internal flash memory. Accessing the internal flash memory of the affected device would require special tools to extract data and carrying out this attack at a healthcare facility would increase the likelihood of detection.

First published (updated )
Severity
5.3
CVSS:3.0/AV:P/AC:L/PR:N/UI:N/S:C/C:H/I:N/A:N

An issue was discovered in Becton, Dickinson and Company (BD) Alaris 8015 Point of Care (PC) unit, Version 9.5 and prior versions, and Version 9.7. An unauthorized user with physical access to an Alaris 8015 PC unit may be able to obtain unencrypted wireless network authentication credentials and other sensitive technical data by disassembling an Alaris 8015 PC unit and accessing the device's flash memory. Older software versions of the Alaris 8015 PC unit, Version 9.5 and prior versions, store wireless network authentication credentials and other sensitive technical data on the affected device's removable flash memory. Being able to remove the flash memory from the affected device reduces the risk of detection, allowing an attacker to extract stored data at the attacker's convenience.

First published (updated )
Severity
2.4
AV:P/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

The FACSChorus workstation does not prevent physical access to its PCI express (PCIe) slots, which could allow a threat actor to insert a PCI card designed for memory capture. A threat actor can then isolate sensitive information such as a BitLocker encryption key from a dump of the workstation RAM during startup.

First published (updated )
Severity
3.5
AV:P/AC:L/PR:L/UI:N/S:U/C:N/I:L/A:L

The FACSChorus software does not properly assign data access privileges for operating system user accounts. A non-administrative OS account can modify information stored in the local application data folders.

First published (updated )
Severity
5.7
AV:P/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:H

The FACSChorus workstation operating system does not restrict what devices can interact with its USB ports. If exploited, a threat actor with physical access to the workstation could gain access to system information and potentially exfiltrate data.

First published (updated )
Severity
5.2
AV:P/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:H

There is no BIOS password on the FACSChorus workstation. A threat actor with physical access to the workstation can potentially exploit this vulnerability to access the BIOS configuration and modify the drive boot order and BIOS pre-boot authentication.

First published (updated )
Severity
5.3
CVSS:3.1/AV:P/AC:H/PR:N/UI:N/S:U/C:L/I:L/A:H

The BD BodyGuard™ infusion pumps specified allow for access through the RS-232 (serial) port interface. If exploited, threat actors with physical access, specialized equipment and knowledge may be able to configure or disable the pump. No electronic protected health information (ePHI), protected health information (PHI) or personally identifiable information (PII) is stored in the pump.

1 / 2
First published (updated )
Severity
7.3
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L

The Alaris Infusion Central software, versions 1.1 to 1.3.2, may contain a recoverable password after the installation. No patient health data is stored in the database, although some site installations may choose to store personal data.

First published (updated )
Severity
8
AV:A/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Default credentials are used in the above listed BD Diagnostic Solutions products. If exploited, threat actors may be able to access, modify or delete data, including sensitive information such as protected health information (PHI) and personally identifiable information (PII). Exploitation of this vulnerability may allow an attacker to shut down or otherwise impact the availability of the system. Note: BD Synapsys™ Informatics Solution is only in scope of this vulnerability when installed on a NUC server. BD Synapsys™ Informatics Solution installed on a customer-provided virtual machine or on the BD Kiestra™ SCU hardware is not in scope.

First published (updated )
Severity
4.3
CVSS:3.1/AV:P/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L

The FACSChorus software database can be accessed directly with the privileges of the currently logged-in user. A threat actor with physical access could potentially gain credentials, which could be used to alter or destroy data stored in the database.

First published (updated )
Severity
6.8
CVSS:3.1/AV:P/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

BD FACSLyric Research Use Only, Windows 10 Professional Operating System, U.S. and Malaysian Releases, between November 2017 and November 2018 and BD FACSLyric IVD Windows 10 Professional Operating System US release does not properly enforce user access control to privileged accounts, which may allow for unauthorized access to administrative level functions.

First published (updated )
Severity
6.8
CVSS:3.1/AV:P/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

The configuration from the PCU can be modified without authentication using physical connection to the PCU.

First published (updated )
Severity
6.7
CVSS:3.1/AV:A/AC:L/PR:L/UI:R/S:U/C:N/I:H/A:H

A GRE dataset file within Systems Manager can be tampered with and distributed to PCUs.

First published (updated )
Severity
6.1
CVSS:3.1/AV:P/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N

The data flowing between the PCU and its modules is insecure. A threat actor with physical access could potentially read or modify data by attaching a specially crafted device while an infusion is running.

First published (updated )
Severity
8.2
XSS
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:H/I:L/A:N

A malicious file could be uploaded into a System Manager User Import Function resulting in a hijacked session.

Remedy

BD recommends customers update to the BD Alarisâ„¢ System v12.3, where available based on regulatory authorization. Customers who require software updates should contact their BD Account Executive to assist with scheduling the remediation.
First published (updated )
Severity
6.9
Input Validation, XSS
CVSS:3.1/AV:A/AC:L/PR:L/UI:R/S:C/C:H/I:L/A:N

Alaris Systems Manager does not perform input validation during the Device Import Function.

Remedy

BD recommends customers update to the BD Alarisâ„¢ System v12.3, where available based on regulatory authorization. Customers who require software updates should contact their BD Account Executive to assist with scheduling the remediation.
First published (updated )
Severity
3.5
CVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N

An insecure connection between Systems Manager and CQI Reporter application could expose infusion data to an attacker.

Remedy

BD recommends customers update to the BD Alarisâ„¢ System v12.3, where available based on regulatory authorization. Customers who require software updates should contact their BD Account Executive to assist with scheduling the remediation.
First published (updated )
Severity
4.3
CVSS:3.1/AV:P/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L

The FACSChorus software contains sensitive information stored in plaintext. A threat actor could gain hardcoded secrets used by the application, which include tokens and passwords for administrative accounts.

First published (updated )
Severity
9.4
CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H

Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port.

First published (updated )
Severity
6.3
SQL Injection
CVSS:3.0/AV:A/AC:H/PR:H/UI:R/S:U/C:H/I:H/A:H

A vulnerability in ReadA version 1.1.0.2 and previous allows an authorized user with access to a privileged account on a BD Kiestra system (Kiestra TLA, Kiestra WCA, and InoqulA+ specimen processor) to issue SQL commands, which may result in loss or corruption of data.

First published (updated )
Severity
8
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

BD Viper LT system, versions 2.0 and later, contains hardcoded credentials. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII). BD Viper LT system versions 4.0 and later utilize Microsoft Windows 10 and have additional Operating System hardening configurations which increase the attack complexity required to exploit this vulnerability.

Remedy

The fix is expected in BD Viper LT system version 4.80 software release.
First published (updated )
Severity
7
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N

Hardcoded credentials are used in specific BD Pyxis products. If exploited, threat actors may be able to gain access to the underlying file system and could potentially exploit application files for information that could be used to decrypt application credentials or gain access to electronic protected health information (ePHI) or other sensitive information.

First published (updated )
Severity
5.6
SQL Injection
CVSS:3.0/AV:A/AC:H/PR:H/UI:R/S:U/C:N/I:H/A:H

A vulnerability in DB Manager version 3.0.1.0 and previous and PerformA version 3.0.0.0 and previous allows an authorized user with access to a privileged account on a BD Kiestra system (Kiestra TLA, Kiestra WCA, and InoqulA+ specimen processor) to issue SQL commands, which may result in data corruption.

First published (updated )
Severity
5.7
CVSS:3.1/AV:P/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:N

BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII).

Remedy

BD Synapsys™ v4.20 SR2 will be released in June 2022 and will remediate this vulnerability. Customers receiving BD Synapsys™ v4.30 will be allowed to upgrade to v5.10, which is expected to be available by August 2022.
First published (updated )
Severity
8.8
CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Specific BD Pyxis™ products were installed with default credentials and may presently still operate with these credentials. There may be scenarios where BD Pyxis™ products are installed with the same default local operating system credentials or domain-joined server(s) credentials that may be shared across product types. If exploited, threat actors may be able to gain privileged access to the underlying file system and could potentially exploit or gain access to ePHI or other sensitive information.

Remedy

BD is currently strengthening our credential management capabilities in BD Pyxis™ products. Service personnel are proactively working with customers whose domain-joined server(s) credentials require updates. BD is currently piloting a credential management solution that is initially targeted for only specific BD Pyxis™ product versions and will allow for improved authentication management practices with specific local operating system credentials. Changes needed for installation, upgrade or to applications are being evaluated as part of the overall remediation.
First published (updated )
Severity
9.8
CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

A hard-coded password issue was discovered in Becton, Dickinson and Company (BD) PerformA, Version 2.0.14.0 and prior versions, and KLA Journal Service, Version 1.0.51 and prior versions. They use hard-coded passwords to access the BD Kiestra Database, which could be leveraged to compromise the confidentiality of limited PHI/PII information stored in the BD Kiestra Database.

First published (updated )
Severity
8.8
CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

In Pyxis ES Versions 1.3.4 through to 1.6.1 and Pyxis Enterprise Server, with Windows Server Versions 4.4 through 4.12, a vulnerability has been identified where existing access privileges are not restricted in coordination with the expiration of access based on active directory user account changes when the device is joined to an AD domain.

First published (updated )
Severity
10
Malicious File Upload
CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H

BD Alaris Gateway Workstation Versions, 1.1.3 Build 10, 1.1.3 MR Build 11, 1.2 Build 15, 1.3.0 Build 14, 1.3.1 Build 13, This does not impact the latest firmware Versions 1.3.2 and 1.6.1, Additionally, the following products using software Version 2.3.6 and below, Alaris GS, Alaris GH, Alaris CC, Alaris TIVA, The application does not restrict the upload of malicious files during a firmware update.

First published (updated )
Severity
5.3
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

BD Alaris Gateway versions, 1.0.13,1.1.3 Build 10,1.1.3 MR Build 11,1.1.5, and 1.1.6, The web browser user interface on the Alaris Gateway Workstation does not prevent an attacker with knowledge of the IP address of the Alaris Gateway Workstation terminal to gain access to the status and configuration information of the device.

First published (updated )

Contact

SecAlerts Pty Ltd.
132 Wickham Terrace
Fortitude Valley,
QLD 4006, Australia
info@secalerts.co
By using SecAlerts services, you agree to our services end-user license agreement. This website is safeguarded by reCAPTCHA and governed by the Google Privacy Policy and Terms of Service. All names, logos, and brands of products are owned by their respective owners, and any usage of these names, logos, and brands for identification purposes only does not imply endorsement. If you possess any content that requires removal, please get in touch with us.
© 2026 SecAlerts Pty Ltd.
ABN: 70 645 966 203, ACN: 645 966 203